Connected devices already enable remote patient monitoring by collecting real-time data, such as injection date and time. With time, these benefits are likely to grow. Following are three areas where manufacturers are exploring new uses of digitalization in drug delivery to better understand the needs of patients and healthcare professionals and create more effective devices.
In general, the Asian markets have controlled the COVID-19 virus successfully outside of China, but its effect has still led to new developments and trends.
With May 26, 2020 quickly approaching, every day counts.
A guide to the steps companies can take to evaluate their device developer’s HFE process.
The device should be carefully matched to end users, rather than be an afterthought.
Via partnerships with pharmaceutical companies, Insulet expands its platform technology past insulin delivery.
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.
Researchers say the technology enables a high drug load and consistent drug release profile.